High-frequency (10 kHz) spinal cord stimulation for the treatment of focal, chronic postsurgical neuropathic pain: results from a prospective study in Belgium

Pain Manag. 2022 Jan;12(1):75-85. doi: 10.2217/pmt-2021-0045. Epub 2021 Jul 22.

Abstract

Aim: Chronic postsurgical pain (CPSP) is a common complication of surgery. This study was conducted to evaluate the efficacy and safety of paresthesia-free, 10-kHz spinal cord stimulation (SCS) as a treatment for CPSP. Patients & methods: Subjects in this prospective, single-arm study had an average pain intensity of ≥5 cm on a 10-cm visual analog scale. The subjects who had pain relief of ≥50% (response) with temporary trial stimulation were permanently implanted with 10-kHz SCS and assessed for 1 year. Results: At 12 months, 94% of subjects were responders to 10-kHz SCS, and 88% had pain remission (visual analog scale ≤2.5 cm). Conclusion: The pain relief was durable in CPSP subjects and the safety profile of 10-kHz SCS was as expected. Clinical Trial registration number: VT005076953 (Privacy Commission of Belgium).

Keywords: chronic pain; neuromodulation; postsurgical pain; spinal cord stimulation.

MeSH terms

  • Belgium
  • Chronic Pain* / therapy
  • Humans
  • Neuralgia* / etiology
  • Neuralgia* / therapy
  • Pain, Postoperative / therapy
  • Prospective Studies
  • Spinal Cord
  • Spinal Cord Stimulation*
  • Treatment Outcome

Grants and funding